Carbon monoxide resistance in Mycobacterium tuberculosis pathogenesis
Carbon monoxide resistance in Mycobacterium tuberculosis pathogenesis
批准号:
8711263
负责人:
MICHAEL SHILOH
金额:
$39.75万
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-09-27 至 2017-08-31
关键词:
AccountingAcidsActive SitesAerosolsAffinity ChromatographyAmino AcidsAntibioticsAntimicrobial ResistanceAttenuatedBacteriaBiochemicalBiochemistryBiological AssayCarbon MonoxideCell SurvivalCellsCessation of lifeCommunicable DiseasesDataDevelopmentDiseaseDrug TargetingDrug resistanceElectron TransportEnvironmental Risk FactorEnzymesEpidemicGasesGenesGlycineGoalsGrowthHemeHistopathologyHomeostasisHost DefenseHumanHypoxiaImmune responseIncidenceInfectionKineticsKnowledgeLibrariesMediatingMetabolicMetabolismMicrobiologyModelingMolecularMolecular ModelsMorbidity - disease rateMusMutateMutationMycobacterium tuberculosisNADHNitric OxideNucleotidesOrganOutcomeOxygenOxygenasesPathogenesisPathway interactionsPeroxonitritePharmaceutical PreparationsPhenotypePhysiologyPopulationPredispositionProteinsProteomicsPyruvate Metabolism PathwayResearchResistanceRoleSystemTestingTherapeutic InterventionTuberculosisVirulenceWorkantimicrobialbasegenetic analysisglobal healthheme oxygenase-1in vivoinhibitor/antagonistkillingsknowledge basemacrophagemetabolomicsmicrobialmolecular modelingmortalitymutantmycobacterialnovelnovel strategiesoverexpressionpathogenreactive oxygen intermediateresearch studyresistance mechanismresponsescreeningtranscriptomicstuberculosis treatment
中文摘要
描述(由申请人提供):结核分枝杆菌仍然是最具破坏性的人类传染病之一,每年造成200万人死亡,并潜伏感染世界三分之一的人口。作为一种适应长期生存的胞内病原菌,M.结核病已经进化出抵抗宿主抗微生物途径杀死的机制。针对这些耐药机制最近已成为治疗M的一种强有力的新方法。通过增强宿主消灭细菌的能力来预防结核病感染。然而,分枝杆菌耐药基因的完整库尚不清楚,扩大这一知识基础为新药的开发提供了额外的途径。我们展示了M。结核病诱导一种酶,血红素加氧酶,产生一氧化碳(CO)气体,并且M.结核杆菌既适应又抵抗CO的杀伤。结核分枝杆菌进化出了抗CO的基因,我们的初步数据表明,M.结核病编码一种这样的基因,当突变时导致毒力减弱。我们将应用代谢组学、转录组学、蛋白质组学和生物化学方法来确定新发现的抗CO蛋白的功能。因此,在拟议的研究中,我们将(1)确定CO抗性的分子机制,(2)确定CO抗性基因的相互作用伴侣及其在CO抗性中的作用,(3)表征CO抗性基因及其相互作用伴侣突变体的致病作用。本文的工作将扩展现有的关于M.结核病的耐药性机制,并揭示了一种新的微生物生存策略。
英文摘要
DESCRIPTION (provided by applicant): Mycobacterium tuberculosis remains one of the most devastating human infectious diseases, causing two million deaths annually and latently infecting a third of the world's population. As an intracellular pathogen adapted to long-term survival, M. tuberculosis has evolved mechanisms to resist killing by host antimicrobial pathways. Targeting those resistance mechanisms has recently emerged as a powerful new approach to treating M. tuberculosis infection by enhancing the host's ability to eradicate the bacteria. However, the full repertoire of mycobacterial resistance genes is not known, and expanding this knowledge base provides additional avenues for the development of new drugs. We demonstrated the M. tuberculosis induces an enzyme, heme oxygenase, that produces carbon monoxide (CO) gas, and that M. tuberculosis both adapts to and resists killing by CO. We hypothesized that M. tuberculosis evolved genes for CO resistance, and our preliminary data indicate that M. tuberculosis encodes one such gene that when mutated results in attenuated virulence. We will apply metabolomic, transcriptomic, proteomic, and biochemical approaches to determine the function of the newly discovered CO resistance protein. Thus, in the proposed research we will (1) identify the molecular mechanism of CO resistance, (2) determine the interacting partners of the CO resistance gene and their role in CO resistance and (3) characterize the pathogenic effects of mutants in the CO resistance gene and its interacting partners. The proposed work will extend the current knowledge on M. tuberculosis's antimicrobial resistance mechanisms and reveal a novel microbial survival strategy.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mechanisms of cough in Mycobacterium tuberculosis transmission
-
批准号:10368154
-
项目类别:
-
资助金额:$72.59万
-
财政年份:2021
-
负责人:MICHAEL SHILOH
-
依托单位:
Project 3: Mechanisms of cough in M. tuberculosis transmission
-
批准号:10404532
-
项目类别:
-
资助金额:$35.28万
-
财政年份:2021
-
负责人:MICHAEL SHILOH
-
依托单位:
Mechanisms of cough in Mycobacterium tuberculosis transmission
-
批准号:10578845
-
项目类别:
-
资助金额:$72.59万
-
财政年份:2021
-
负责人:MICHAEL SHILOH
-
依托单位:
Project 3: Mechanisms of cough in M. tuberculosis transmission
-
批准号:10190651
-
项目类别:
-
资助金额:$51.74万
-
财政年份:2021
-
负责人:MICHAEL SHILOH
-
依托单位:
Project 3: Mechanisms of cough in M. tuberculosis transmission
-
批准号:10610926
-
项目类别:
-
资助金额:$35.03万
-
财政年份:2021
-
负责人:MICHAEL SHILOH
-
依托单位:
Mechanisms of cough in Mycobacterium tuberculosis transmission
-
批准号:10185506
-
项目类别:
-
资助金额:$70.77万
-
财政年份:2021
-
负责人:MICHAEL SHILOH
-
依托单位:
RP4: Harnessing autophagy to treat tuberculosis
-
批准号:10573263
-
项目类别:
-
资助金额:$155.64万
-
财政年份:2019
-
负责人:MICHAEL SHILOH
-
依托单位:
RP4: Harnessing autophagy to treat tuberculosis
-
批准号:10364726
-
项目类别:
-
资助金额:$143.51万
-
财政年份:2019
-
负责人:MICHAEL SHILOH
-
依托单位:
Human airway microfold cells in mucosal immunity to bacterial pathogens
-
批准号:9170079
-
项目类别:
-
资助金额:$45.64万
-
财政年份:2016
-
负责人:MICHAEL SHILOH
-
依托单位:
Identification of novel M. tuberculosis secreted effector proteins
-
批准号:8796158
-
项目类别:
-
资助金额:$23.51万
-
财政年份:2014
-
负责人:MICHAEL SHILOH
-
依托单位:
Identification of novel M. tuberculosis secreted effector proteins
-
批准号:8682011
-
项目类别:
-
资助金额:$19.53万
-
财政年份:2014
-
负责人:MICHAEL SHILOH
-
依托单位:
Carbon monoxide resistance in Mycobacterium tuberculosis pathogenesis
-
批准号:8900916
-
项目类别:
-
资助金额:$39.75万
-
财政年份:2012
-
负责人:MICHAEL SHILOH
-
依托单位:
Carbon monoxide resistance in Mycobacterium tuberculosis pathogenesis
-
批准号:8438755
-
项目类别:
-
资助金额:$39.75万
-
财政年份:2012
-
负责人:MICHAEL SHILOH
-
依托单位:
Carbon monoxide resistance in Mycobacterium tuberculosis pathogenesis
-
批准号:9113479
-
项目类别:
-
资助金额:$39.75万
-
财政年份:2012
-
负责人:MICHAEL SHILOH
-
依托单位:
Carbon monoxide resistance in Mycobacterium tuberculosis pathogenesis
-
批准号:8554358
-
项目类别:
-
资助金额:$37.37万
-
财政年份:2012
-
负责人:MICHAEL SHILOH
-
依托单位:
Carbon monoxide in Mycobacterium tuberculosis pathogenesis
-
批准号:7846226
-
项目类别:
-
资助金额:$5.59万
-
财政年份:2008
-
负责人:MICHAEL SHILOH
-
依托单位:
Carbon monoxide in Mycobacterium tuberculosis pathogenesis
-
批准号:8234541
-
项目类别:
-
资助金额:$6.59万
-
财政年份:2008
-
负责人:MICHAEL SHILOH
-
依托单位:
Carbon monoxide in Mycobacterium tuberculosis pathogenesis
-
批准号:7532872
-
项目类别:
-
资助金额:$12.16万
-
财政年份:2008
-
负责人:MICHAEL SHILOH
-
依托单位:
Carbon monoxide in Mycobacterium tuberculosis pathogenesis
-
批准号:7631191
-
项目类别:
-
资助金额:$12.18万
-
财政年份:2008
-
负责人:MICHAEL SHILOH
-
依托单位:
RP4: Harnessing autophagy to treat tuberculosis
-
批准号:9893814
-
项目类别:
-
资助金额:$174.07万
-
财政年份:--
-
负责人:MICHAEL SHILOH
-
依托单位:
国内基金
海外基金
登录
查看更多内容
抗禾谷镰刀菌3-Decalinoyltetramic Acids类天然产物的挖掘及基于“靶标垂钓”策略的作用机制研究
-
批准号:32470420
-
项目类别:面上项目
-
资助金额:50.00万元
-
批准年份:2024
-
负责人:赵栋霖
-
依托单位:
真菌中同一PKS-NRPS基因簇合成两种不同骨架tetramic acids机制研究
-
批准号:32470051
-
项目类别:面上项目
-
资助金额:50.00万元
-
批准年份:2024
-
负责人:张伟
-
依托单位:
具有抗癌活性的天然产物金霉酸(Aureolic acids)全合成与选择性构建2-脱氧糖苷键
-
批准号:22007039
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:王黎明
-
依托单位:
海洋放线菌来源聚酮类化合物Pteridic acids生物合成机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2019
-
负责人:朱义广
-
依托单位:
手性Lewis Acids催化的分子内串联1,5-氢迁移/环合反应及其在构建结构多样性手性含氮杂环化合物中的应用
-
批准号:21372217
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2013
-
负责人:袁伟成
-
依托单位:
对空气稳定的新型的有机金属Lewis Acids催化剂制备、表征与应用研究
-
批准号:21172061
-
项目类别:面上项目
-
资助金额:30.0万元
-
批准年份:2011
-
负责人:许新华
-
依托单位:
钛及含钛Lewis acids促臭氧/过氧化氢体系氧化性能的广普性、高效性及其机制
-
批准号:21176225
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2011
-
负责人:童少平
-
依托单位:
基于Zip Nucleic Acids引物对高度降解和低拷贝DNA检材的STR分型研究
-
批准号:81072511
-
项目类别:面上项目
-
资助金额:31.0万元
-
批准年份:2010
-
负责人:严江伟
-
依托单位:
海洋天然产物Makaluvic acids 的全合成及其对南海鱼虱存活的影响
-
批准号:30660215
-
项目类别:地区科学基金项目
-
资助金额:21.0万元
-
批准年份:2006
-
负责人:王世范
-
依托单位: